[1] JACK C R,BENNETT D A,BLENNOW K,et al.NIA-AA Research Framework:toward a biologicaldefinition of Alzheimer's disease[J]. AlzheimersDement,2018,14(4):535-562.[2] SILVERBERG N,ELLIOTT C,RYAN L,et al. NIAcommentary on the NIA-AA Research Framework:towards a biological definition of Alzheimer’sdisease[J]. Alzheimers Dement,2018,14(4):576-578.[3] LIVINGSTON G,SOMMERLAD A,ORGETA V,et al. Dementia prevention,intervention,and care[J].Lancet,2017,390(10 113):2673-2734.[4] JACK C R,BENNETT D A,BLENNOW K,et al.A/T/N:an unbiased descriptive classification schemefor Alzheimer disease biomarkers[J]. Neurology,2016,87(5):539-547.[5] DE WILDE A,VAN DER FLIER W M,PELKMANS W,et al. Association of amyloidpositron emission tomography with changes indiagnosis and patient treatment in an unselectedmemory clinic cohort:the ABIDE project[J]. JAMANeurol,2018,75(9):1062-1070.[6] 顾小花,徐俊,程欣欣,等. 脑淀粉样血管病所致脑出血的免疫性血管病理损害初步研究[J]. 中国卒中杂志,2016,11(8):631-635.[7] 唐亚娟,赵继宗,李永,等. 自发性脑出血与淀粉样脑血管病相关性研究[J]. 中华医学杂志,2010,90(15):1016-1019.[8] CHARIDIMOU A,FARID K,TSAI H H,et al.Amyloid-PET burden and regional distribution incerebral amyloid angiopathy:a systematic reviewand meta-analysis of biomarker performance[J]. JNeurol Neurosurg Psychiatry,2018,89(4):410-417.[9] RABIN J S,YANG H S,SCHULTZ A P,et al.Vascular risk and β-amyloid are synergisticallyassociated with cortical Tau[J]. Ann Neurol,2019,85(2):272-279.[10] KJELDSEN S E,NARKIEWICZ K,BURNIERM,et al. Intensive blood pressure lowering preventsmild cognitive impairment and possible dementiaand slows development of white matter lesionsin brain:the SPRINT Memory and Cognition INDecreased Hypertension(SPRINT MIND)study[J].Blood Press,2018,27(5):247-248.[11] BRAYNE C. Dementia research 2018:current andfuture population relevance[J]. Lancet Neurol,2019,18(1):3-5.